Advertisement

Picture EBD Group BIO-Europe Spring 2020 Paris BEU2020 650x75
Document › Details

GeNeuro S.A.. (1/31/20). "Press Release: GeNeuro Announces Successful €17.5 Million Private Placement [Not for United States, Australia, Canada, Japan, South Africa or any other Jurisdiction where Unlawful]". Geneva.

Organisation Organisation GeNeuro S.A. (Euronext Paris: GNRO)
Products Product temelimab (pHER-W Env MAb)
  Product 2 investment banking
Persons Person Martin-Garcia, Jesús (Eclosion 201207 General Partner + Founder + GeNeuro 201512 CEO)
  Person 2 Bohin, Mathilde (NewCap 201809)
     


   
Record changed: 2020-02-10

Advertisement

Picture [iito] – Putting Information into Context 650x65px

More documents for GeNeuro S.A. (Euronext Paris: GNRO)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px




» top